Literature DB >> 131666

Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.

D S Nelson, J M Penrose, M F Waters, J M Pearson, M Nelson.   

Abstract

Mixed leucocyte cultures, from two normal donors, were set up in media containing human serum from one of the following sources: (a) a pool of normal group AB donors; (b) Chinese, Malay or Indian patients with untreated leprosy; (c) the same patients after effective anti-leprosy treatment; (d) control Chinese, Malay or Indian subjects. Transformation was estimated by measuring the incorporation of tritiated thymidine in the last 24 hr of a 7-day culture period. Transformation was impaired in sera from treated lepromatous patients, but was less impaired or not impaired at all in sera from treated lepromatous patients. The loss of depressive activity after treatment was more marked in Chinese and Indian than in Malay patients. Transformation was also impaired, though to a lesser extent, in sera from patients with untreated tuberculoid leprosy; it was still impaired in sera from treated tuberculoid patients. There was no evidence of specificity in impairment of mixed lymphocyte reactivity and lymphocytotoxic antibodies appeared to play no role. The incidences of hepatitis B antigen and antibody and of anti-nuclear factor were not notably high.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 131666      PMCID: PMC1538440     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Association between lepromatous leprosy and Australia antigen.

Authors:  B S Blumberg; L Melartin; M Lechat; R S Guinto
Journal:  Lancet       Date:  1967-07-22       Impact factor: 79.321

2.  Typing for MLC (LD). II. The selection of nonstimulator cells by MLC inhibition tests using SD-indentical stimulator cells (MISIS) and fluorescence antibody studies.

Authors:  A van Leeuwen; H R Schuit; J J van Rood
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

3.  Inhibitory effect of Australia-positive sera on in-vitro-stimulated T lymphocytes.

Authors:  J Clot; O Mathieu; S Elharrar; M Robinet-Levy; J M Lemaire
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

4.  The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.

Authors:  S R Cooperband; A M Badger; R C Davis; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

Review 5.  LD-SD interaction in vivo and the allograft reaction.

Authors:  J J van Rood
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

6.  Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex.

Authors:  M B Widmer; B J Alter; F H Bach; M L Bach
Journal:  Nat New Biol       Date:  1973-04-25

7.  Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

8.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

9.  Production by stimulated macrophages of factors depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Nature       Date:  1973-11-30       Impact factor: 49.962

10.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep
View more
  13 in total

1.  [Immune defect syndrome in Crohn's disease (author's transl)].

Authors:  K Kleesiek; E Masseck; Z Pusztai-Markos; W Spölgen; T Raguse; H P Bräcker
Journal:  Klin Wochenschr       Date:  1978-12-15

2.  Immune responses to mycobacteria in mice and men.

Authors:  G A Rook
Journal:  Proc R Soc Med       Date:  1976-06

3.  Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.

Authors:  H Mejia-López; O Vaca-García; J M Cristerna-Aguirre; A Cruz-Chávez; M Selman-Lama; M L Taylor
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 4.  Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.

Authors:  G Bjune; O Closs; R S Barnetson
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

5.  Studies on T cell subsets and functions in leprosy.

Authors:  M A Bach; L Chatenoud; D Wallach; F Phan Dinh Tuy; F Cottenot
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

6.  Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms.

Authors:  C A Brown; I N Brown
Journal:  Br J Exp Pathol       Date:  1982-04

7.  Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

Authors:  G M Bahr; G A Rook; E Moreno; P M Lydyard; F Z Modabber; J L Stanford
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

8.  Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  M A Kerr; Y M Hussein; R C Potts; J S Beck; M M Sheriff
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

9.  Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae.

Authors:  C N Oster; R H Kenyon; C E Pedersen
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

10.  Lymphocyte transformation test in leprosy: decreased lymphocyte reactivity to Mycobacterium leprae in lepromatous leprosy, with no evidence for a generalized impairment.

Authors:  W R Faber; D L Leiker; I M Nengerman; W P Zeijlemaker; P T Schellekens
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.